This week’s ‘Sneak Peek’ of the AI BioHub brought together a vibrant cross-section of the life sciences and tech communities—engineers, biotech entrepreneurs, investors, and community leaders—united not just by curiosity about a new lab in the making, but by a shared belief in the power of AI to shape the future of scientific progress. 

LabCentral CEO Maggie O’Toole opened the evening by welcoming the crowd and setting the stage for a program that reflects both the urgency and the promise of this convergence. “The intersection of AI and tech is really where the next generation of science is going to come,” she said. “And we want to make sure that LabCentral is poised to support that.” 

The event was also a chance to hear directly from the founders applying to join the inaugural cohort of the AI Bio Accelerator Program. Each shared a vision for how AI can unlock new approaches in areas like computational drug design, precision diagnostics, and patient-centered platforms.  

Toward the end of the program, attendees were invited to grab a Sharpie and sign their names on the bare concrete floor of Lab 178—the future home of the AI BioHub. What might have seemed like a playful gesture took on real symbolic weight. It was an acknowledgment that the future of AIxBio is being built by this community. 

Speakers from across the AI BioHub’s leadership and advisory group shared insights into the program’s vision. Anna Marie Wagner reflected on the bridge between biology and computer science: 

“There's something magical that can happen right now because AI is a very biological substrate in a way that traditional computer programming never was. It allows us to translate [and] speak the same language. . . We can bring these really powerful, exponentially improving technologies together in a way that we couldn't for the past several decades." 

And Shahid Azim, C10’s CEO, added another perspective: 

“It's at this intersection where we can bring some fresh thinking . . . and fundamentally challenge the assumptions that are so ingrained in certain industries, unlocking what's possible. Things that used to take months now take hours and days.” 

Supported by a $1.9M grant from the Innovation Institute at the Massachusetts Technology Collaborative, and designed in partnership with C10 Labs, the AI BioHub is more than a physical space. It’s a mindset, a network, and a commitment to accelerating meaningful innovation in human health. 

There’s still time to get involved. If you’re an early-stage company building at the AI/biotech frontier, applications to the AI Bio Accelerator are open—apply now!  

We’re also actively building our mentor network. If you have deep expertise in AI, biotech, product development, or company-building—and a desire to support the next generation of transformative startups—we’d love to hear from you. 

There’s a spark here. And it’s only the beginning.